Susac syndrome: clinical features, laboratory testing and treatment responses of 20 cases

dc.authoridTERZİ, Murat/0000-0002-3586-9115
dc.authoridBoz, Cavit/0000-0003-0956-3304
dc.authoridSAİP, SABAHATTİN/0000-0002-2802-7227
dc.authorwosidTERZİ, Murat/AAA-1284-2021
dc.authorwosidBOZ, Cavit/V-5127-2017
dc.authorwosidTUNCER, ALAETTİN/G-5958-2013
dc.authorwosidBoz, Cavit/AAR-2268-2020
dc.authorwosidZengin Karahan, Serap/HHS-0268-2022
dc.authorwosidSAİP, SABAHATTİN/AAE-2410-2021
dc.contributor.authorKarahan, S. Z.
dc.contributor.authorBoz, C.
dc.contributor.authorUsta, N. C.
dc.contributor.authorSaip, S.
dc.contributor.authorKale, N.
dc.contributor.authorDemirkaya, S.
dc.contributor.authorTuncer, A.
dc.date.accessioned2024-06-12T11:23:59Z
dc.date.available2024-06-12T11:23:59Z
dc.date.issued2017
dc.departmentTrakya Üniversitesien_US
dc.description7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) -- OCT 25-28, 2017 -- Paris, FRANCEen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosis,Americas Comm Treatment & Res Multiple Sclerosisen_US
dc.identifier.endpage91en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.startpage90en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26761
dc.identifier.volume23en_US
dc.identifier.wosWOS:000413730200141en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleSusac syndrome: clinical features, laboratory testing and treatment responses of 20 casesen_US
dc.typeConference Objecten_US

Dosyalar